SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Clinical trials for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) trials appear
Sign up with your email to follow new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to cut pneumonia deaths with precision steroid dosing
Disease control Not yet recruitingThis study tests whether giving the right amount of anti-inflammatory medicine (corticosteroids) can lower the high death rate (25-50%) in severe pneumonia patients in the ICU. It focuses on two specific causes: adenovirus and Pneumocystis jirovecii. About 1,500 adults will be ra…
Matched conditions: SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Phase: PHASE2, PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Global pneumonia study seeks to uncover best practices for saving lives
Knowledge-focused Not yet recruitingThis study will observe about 2,600 adults hospitalized with severe pneumonia that started outside the hospital. Researchers want to see how different hospitals around the world treat this condition and how those treatments affect recovery. No new drugs or procedures are tested—o…
Matched conditions: SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated May 26, 2026 12:11 UTC